VeriMom¿Es potassium phenylbenzimidazole sulfonate seguro durante el embarazo?
Potassium phenylbenzimidazole sulfonate (the water‑soluble salt of phenylbenzimidazole sulfonic acid, INCI often reported as Phenylbenzimidazole Sulfonic Acid/its salts) is a UVB filter with no harmonised reproductive classification and no convincing animal or human reproductive/toxic endocrine data in regulatory reviews; CIR/SCCS assessments do not identify reproductive hazard. Dermal absorption is low but measurable for this class of water‑soluble UV filters, so exposure in pregnancy is low but not zero (SCCS/CosIng/PubChem summaries).
Related ingredients
Frequently asked questions
- ¿Es potassium phenylbenzimidazole sulfonate seguro durante el embarazo?
- Potassium phenylbenzimidazole sulfonate (the water‑soluble salt of phenylbenzimidazole sulfonic acid, INCI often reported as Phenylbenzimidazole Sulfonic Acid/its salts) is a UVB filter with no harmonised reproductive classification and no convincing animal or human reproductive/toxic endocrine data in regulatory reviews; CIR/SCCS assessments do not identify reproductive hazard. Dermal absorption is low but measurable for this class of water‑soluble UV filters, so exposure in pregnancy is low but not zero (SCCS/CosIng/PubChem summaries).
- ¿Es potassium phenylbenzimidazole sulfonate seguro durante la lactancia?
- Same rationale as for pregnancy: no regulatory harmonised reproductive or lactation hazard identified and no mechanistic evidence for transfer into milk in available safety assessments; dermal exposure is low but measurable, so postpartum topical use implies low maternal systemic exposure and therefore low likelihood of meaningful transfer into breast milk (SCCS/CosIng/PubChem).
- ¿Es potassium phenylbenzimidazole sulfonate seguro para la piel del bebé?
- No infant‑specific reproductive or developmental hazards reported; however, due to immature infant barrier and higher surface‑area‑to‑body‑weight, measurable dermal absorption of this water‑soluble UV filter warrants increasing exposure score for 0–3 year skin to moderate. Regulatory safety reviews (SCCS/CosIng) do not flag developmental or endocrine concerns but note exposure considerations for application to young children.
- ¿Cómo puntúa VeriMom a potassium phenylbenzimidazole sulfonate?
- VeriMom puntúa potassium phenylbenzimidazole sulfonate en 93/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a potassium phenylbenzimidazole sulfonate en el embarazo?
- Consulta nuestra lista de alternativas seguras a potassium phenylbenzimidazole sulfonate según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.